Alex Waldron
About
Alex Waldron is from Greater Boston. Alex is currently Chief Executive Officer at Neutargeton Therapeutics. Alex also works as Entrepreneur in Residence at Yale Ventures, a job Alex has held since Sep 2022. Another title Alex currently holds is Chief Strategy Officer (CSO) at Pear Therapeutics. In Alex's previous role as a Independent Board Member at Embr Labs, Alex worked in Greater Boston until Oct 2023. Prior to joining Embr Labs, Alex was a Chief Executive Officer at Wellinks and held the position of Chief Executive Officer at New Haven, Connecticut, United States.
Alex Waldron's email is available on Finalscout.com free of charge. This database has a wealth of information on over half a billion business professionals and two hundred million companies.